Literature DB >> 7777193

Increased cerebrospinal fluid tau in patients with Alzheimer's disease.

M Jensen1, H Basun, L Lannfelt.   

Abstract

One of the pathological features in Alzheimer's disease (AD) is neurofibrillary tangles in the brain. The main constituent of tangles is the microtubuli-associated protein tau in a hyperphosphorylated state. Tau is also released into cerebrospinal fluid (CSF), and in this study we have used an enzyme linked immunosorbent assay to measure tau in CSF from AD and control cases. Our findings show that tau levels in AD cases are significantly elevated compared to healthy control individuals. We suggest that tau may serve as a biochemical marker of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777193     DOI: 10.1016/0304-3940(95)11297-a

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Both total and phosphorylated tau are increased in Alzheimer's disease.

Authors:  M Sjögren; P Davidsson; M Tullberg; L Minthon; A Wallin; C Wikkelso; A K Granérus; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 2.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

3.  A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test.

Authors:  K Ghanbari; H A Ghanbari
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease.

Authors:  Susanna Levy; Matthew McConville; Glorie A Lazaro; Paul Averback
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 5.  The role of tau in Alzheimer's disease and related disorders.

Authors:  Rodrigo Medeiros; David Baglietto-Vargas; Frank M LaFerla
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

6.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.

Authors:  Yi-Yu Chou; Natasha Leporé; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

7.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.

Authors:  Lidia Glodzik-Sobanska; Elizabeth Pirraglia; Miroslaw Brys; Susan de Santi; Lisa Mosconi; Kenneth E Rich; Remigiusz Switalski; Leslie Saint Louis; Martin J Sadowski; Frank Martiniuk; Pankaj Mehta; Domenico Pratico; Raymond P Zinkowski; Kaj Blennow; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-10-24       Impact factor: 4.673

8.  Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.

Authors:  Celeste M Karch; Amanda T Jeng; Alison M Goate
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

9.  Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.

Authors:  H Ghanbari; K Ghanbari; I Beheshti; M Munzar; A Vasauskas; P Averback
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 10.  Biomarkers of Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Anne M Fagan; David M Holtzman
Journal:  Neurobiol Dis       Date:  2008-10-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.